Compare OESX & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OESX | XLO |
|---|---|---|
| Founded | 1996 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.4M | 49.8M |
| IPO Year | 2007 | 2021 |
| Metric | OESX | XLO |
|---|---|---|
| Price | $10.29 | $9.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $17.50 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 44.8K | 32.9K |
| Earning Date | 02-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $86,306,000.00 | $43,766,000.00 |
| Revenue This Year | $7.94 | N/A |
| Revenue Next Year | $13.89 | $168.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 8.26 | ★ 589.88 |
| 52 Week Low | $0.55 | $0.46 |
| 52 Week High | $18.64 | $9.89 |
| Indicator | OESX | XLO |
|---|---|---|
| Relative Strength Index (RSI) | 48.76 | 56.25 |
| Support Level | $8.60 | $7.47 |
| Resistance Level | $10.38 | $9.89 |
| Average True Range (ATR) | 0.88 | 0.40 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 31.87 | 43.17 |
Orion Energy Systems Inc provide light emitting diode (LED) lighting systems, wireless Internet of Things (IoT) enabled control solutions, commercial and industrial electric vehicle charging infrastructure solutions and lighting and electrical maintenance services. It help its customers achieve their sustainability, energy savings and carbon footprint reduction goals through technology and exceptional service. It sell its products and services into many vertical markets within the broader commercial and industrial market segment. Primary verticals include box retail, manufacturing, warehousing/logistics, federal and municipal government, healthcare and schools. It has three segments Lighting, Maintenance, and EV segment. It generates majority of revenue from Lighting segment.
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.